87 related articles for article (PubMed ID: 18465691)
1. [The role of peroxisome proliferators-activated receptors (PPARgamma) in neoplasms of endocrine glands].
Winczyk K
Endokrynol Pol; 2008; 59(2):156-66. PubMed ID: 18465691
[TBL] [Abstract][Full Text] [Related]
2. Effects of rosiglitazone--peroxisome proliferators-activated receptor gamma (PPARgamma) agonist on cell viability of human pituitary adenomas in vitro.
Winczyk K; Kunert-Radek J; Gruszka A; Radek M; Ławnicka H; Pawlikowski M
Neuro Endocrinol Lett; 2009 Mar; 30(1):107-10. PubMed ID: 19300395
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor gamma in the human pituitary gland: expression and splicing pattern in adenomas versus normal pituitary.
Occhi G; Albiger N; Berlucchi S; Gardiman M; Scanarini M; Scienza R; Fassina A; Mantero F; Scaroni C
J Neuroendocrinol; 2007 Jul; 19(7):552-9. PubMed ID: 17561883
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of PPARgamma receptors in the human pituitary adenomas: correlation with PCNA.
Winczyk K; Pawlikowski M
Folia Histochem Cytobiol; 2005; 43(3):137-41. PubMed ID: 16201313
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor γ-mediated induction of microRNA-145 opposes tumor phenotype in colorectal cancer.
Panza A; Votino C; Gentile A; Valvano MR; Colangelo T; Pancione M; Micale L; Merla G; Andriulli A; Sabatino L; Vinciguerra M; Prattichizzo C; Mazzoccoli G; Colantuoni V; Piepoli A
Biochim Biophys Acta; 2014 Jun; 1843(6):1225-36. PubMed ID: 24631504
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effects of peroxisome proliferator activate receptor gamma ligands on anaplastic thyroid carcinoma.
Hayashi N; Nakamori S; Hiraoka N; Tsujie M; Xundi X; Takano T; Amino N; Sakon M; Monden M
Int J Oncol; 2004 Jan; 24(1):89-95. PubMed ID: 14654945
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of peroxisome poliferator-activated receptor gamma on thyroid carcinoma cell growth.
Martelli ML; Iuliano R; Le Pera I; Sama' I; Monaco C; Cammarota S; Kroll T; Chiariotti L; Santoro M; Fusco A
J Clin Endocrinol Metab; 2002 Oct; 87(10):4728-35. PubMed ID: 12364466
[TBL] [Abstract][Full Text] [Related]
8. A widely used retinoic acid receptor antagonist induces peroxisome proliferator-activated receptor-gamma activity.
Schupp M; Curtin JC; Kim RJ; Billin AN; Lazar MA
Mol Pharmacol; 2007 May; 71(5):1251-7. PubMed ID: 17290005
[TBL] [Abstract][Full Text] [Related]
9. Identification of a paired box gene 8-peroxisome proliferator-activated receptor gamma (PAX8-PPARgamma) rearrangement mosaicism in a patient with an autonomous functioning follicular thyroid carcinoma bearing an activating mutation in the TSH receptor.
Lado-Abeal J; Celestino R; Bravo SB; Garcia-Rendueles ME; de la Calzada J; Castro I; Castro P; Espadinha C; Palos F; Soares P; Alvarez CV; Sobrinho-Simões M; Cameselle-Teijeiro J
Endocr Relat Cancer; 2010 Sep; 17(3):599-610. PubMed ID: 20427420
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of lymphoma cell proliferation by peroxisomal proliferator-activated receptor-γ ligands via Wnt signaling pathway.
Liu JJ; Dai XJ; Xu Y; Liu PQ; Zhang Y; Liu XD; Fang ZG; Lin DJ; Xiao RZ; Huang RW; Huang HQ
Cell Biochem Biophys; 2012 Jan; 62(1):19-27. PubMed ID: 21837368
[TBL] [Abstract][Full Text] [Related]
11. 6-Shogaol inhibits breast and colon cancer cell proliferation through activation of peroxisomal proliferator activated receptor γ (PPARγ).
Tan BS; Kang O; Mai CW; Tiong KH; Khoo AS; Pichika MR; Bradshaw TD; Leong CO
Cancer Lett; 2013 Aug; 336(1):127-39. PubMed ID: 23612072
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator activated receptor-gamma (PPARgamma) represses thyroid hormone signaling in growth plate chondrocytes.
Wang L; Shao YY; Ballock RT
Bone; 2005 Sep; 37(3):305-12. PubMed ID: 16023420
[TBL] [Abstract][Full Text] [Related]
13. Thiazolidinedione drugs down-regulate CXCR4 expression on human colorectal cancer cells in a peroxisome proliferator activated receptor gamma-dependent manner.
Richard CL; Blay J
Int J Oncol; 2007 May; 30(5):1215-22. PubMed ID: 17390024
[TBL] [Abstract][Full Text] [Related]
14. Cystathionine γ lyase-hydrogen sulfide increases peroxisome proliferator-activated receptor γ activity by sulfhydration at C139 site thereby promoting glucose uptake and lipid storage in adipocytes.
Cai J; Shi X; Wang H; Fan J; Feng Y; Lin X; Yang J; Cui Q; Tang C; Xu G; Geng B
Biochim Biophys Acta; 2016 May; 1861(5):419-29. PubMed ID: 26946260
[TBL] [Abstract][Full Text] [Related]
15. Roles of peroxisome proliferator-activated receptor-alpha and -gamma in the development of non-small cell lung cancer.
Li MY; Yuan H; Ma LT; Kong AW; Hsin MK; Yip JH; Underwood MJ; Chen GG
Am J Respir Cell Mol Biol; 2010 Dec; 43(6):674-83. PubMed ID: 20081051
[TBL] [Abstract][Full Text] [Related]
16. Expression of the two alternatively spliced PRKAR1A RNAs in human endocrine glands.
Peverelli E; Mantovani G; Bondioni S; Pellegrini C; Bosari S; Lania AG; Beck-Peccoz P; Spada A
Mol Cell Endocrinol; 2005 Jun; 238(1-2):51-5. PubMed ID: 15921845
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor gamma inhibits follicular and anaplastic thyroid carcinoma cells growth by upregulating p21Cip1/WAF1 gene in a Sp1-dependent manner.
Bonofiglio D; Qi H; Gabriele S; Catalano S; Aquila S; Belmonte M; Andò S
Endocr Relat Cancer; 2008 Jun; 15(2):545-57. PubMed ID: 18509005
[TBL] [Abstract][Full Text] [Related]
18. Biology of PPAR gamma in cancer: a critical review on existing lacunae.
Krishnan A; Nair SA; Pillai MR
Curr Mol Med; 2007 Sep; 7(6):532-40. PubMed ID: 17896990
[TBL] [Abstract][Full Text] [Related]
19. The peroxisome proliferator-activated receptor N-terminal domain controls isotype-selective gene expression and adipogenesis.
Hummasti S; Tontonoz P
Mol Endocrinol; 2006 Jun; 20(6):1261-75. PubMed ID: 16556736
[TBL] [Abstract][Full Text] [Related]
20. [Expression of peroxisome proliferator-activated receptor-gamma in human pituitary adenomas and its correlation to tumor invasiveness].
Huang CX; Hou YH; Zhao JN; Wang YT; Li JJ; Wen L
Ai Zheng; 2008 Jun; 27(6):590-4. PubMed ID: 18570731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
